A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites

Journal of Applied Clinical Medical Physics

Volumn 15, Issue 5, 2014, Pages 196-206

  Pulliam, Kiley B ^a   Followill, David ^b   Court, Laurence ^b   Dong, Lei ^a,c   Gillin, Michael ^b   Prado, Karl ^d   Kry, Stephen F ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Scripps Proton Therapy Center   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Gamma; IMRT QA; Patient specific QA; Quality assurance

Indexed keywords

EID: 84907022995     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v15i5.4935     Document Type: Article

References (14)

1. Carrasco P, Jornet N, Latoree A, Eudaldo T, Ruiz A, Ribas M. 3D DVH-based metric analysis versus per-beam planar analysis in IMRT pretreatment verification. Med Phys. 2012;39(8):5040-49.
2. Zhen H, Nelms BE, Tome WA. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. Med Phys. 2011;38(10):5477-89.
3. Mans A, Wendling M, McDermott LN, et al. Catching errors with in vivo EPID dosimetry. Med Phys. 2010;37(6):2638-44.
4. van Elmpt W, Nijsten S, Mijnheer B, Dekker A, Lambin P. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations. Radiother Oncol. 2008;86(1):86-92.
5. Wu C, Hosier K, Beck K, et al. On using 3D γ-analysis for IMRT and VMAT pretreatment plan QA. Med Phys. 2012;39(6):3051-59.
6. Kruse JJ. On the insensitivity of single field planar dosimetry to IMRT inaccuracies. Med Phys. 2010;37(6):2516-24.
7. Nelms BE and Simon WE, inventors. Sun Nuclear Corp., assignee. Radiation therapy plan dose perturbation system and method. United States patent 7945022 B2. 2011 May 17.
8. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359-73.
9. Dong L, Antolak J, Salehpour M, et al. Patient-specific point dose measurement for IMRT monitor unit verification. Int J Radiat Oncol Biol Phys. 2003;56(3):867-77.
10. Fenoglietto P, Laliberte B, Ailleres N, Riou O, Dubois JB, Azria D. Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the Montpellier Comprehensive Cancer Center. Radiat Oncol. 2011;6:1-11.
11. Pulliam KB, Howell RM, Follwill D, Luo D, White RA, Kry SF. The clinical impact of the couch top and rails on IMRT and arc therapy. Phys Med Biol. 2011;56(23):7435-47.
12. Nelms BE and Simon JA. A survey on planar IMRT QA analysis. J Appl Clin Med Phys. 2007;8(3):76-90.
13. McKenzie EM. An evaluation of the consistency of IMRT patient-specific QA techniques [thesis]. Houston, TX: University of Texas; 2013. Retrieved from Digital Commons at the Texas Medical Center.
14. Howell RM, Smith IPN, Jarrio CS. Establishing action levels for EPID-based QA for IMRT. J Appl Clin Med Phys. 2008:9(3):16-25.